Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies
Clinical trial NCT03682029 · UNKNOWN
Trial details
- NCT number
- NCT03682029
- Sponsor
- Rigshospitalet, Denmark
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-21
- Primary completion
- 2023-09-27
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.